{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:08:13Z","timestamp":1787170093065,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Purpose\u2014<\/jats:title>\n                    <jats:p>Current ischemic stroke reperfusion therapy consists of intravenous thrombolysis given in eligible patients after review of a noncontrast CT scan and a time-based window of opportunity. Rapid clot lysis has a strong association with clinical improvement but remains incomplete in many patients. This review appraises novel adjunctive or alternative approaches to current reperfusion strategies being tested in all trial phases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary of Review\u2014<\/jats:title>\n                    <jats:p>Alternative approaches to current reperfusion therapy can be separated into 4 main categories: (1) combinatory approaches with other drugs or devices; (2) novel systemic thrombolytic agents; (3) endovascular medical or mechanical reperfusion treatments; and (4) noninvasive or minimally invasive methods to augment cerebral blood flow and alleviate intracranial blood flow steal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\u2014<\/jats:title>\n                    <jats:p>Reperfusion treatments must be provided as fast as possible in patients most likely to benefit. Patients who fail to rapidly reperfuse may benefit from other strategies that maintain collateral flow or protect tissue at risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/strokeaha.111.617902","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T06:27:15Z","timestamp":1325831235000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Adjunctive and Alternative Approaches to Current Reperfusion Therapy"],"prefix":"10.1161","volume":"43","author":[{"given":"Andrew D.","family":"Barreto","sequence":"first","affiliation":[{"name":"From the Department of Neurology (A.D.B.), Stroke Program; The University of Texas\u2013Houston Medical School, Houston, TX; and the Comprehensive Stroke Center (A.V.A.), Department of Neurology, University of Alabama\u2013Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Alexandrov","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.D.B.), Stroke Program; The University of Texas\u2013Houston Medical School, Houston, TX; and the Comprehensive Stroke Center (A.V.A.), Department of Neurology, University of Alabama\u2013Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.192535"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071253"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320113"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000257304.21967.ba"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00107-2"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.69.143"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.67.6.1552"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hs1101.097390"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000131549.20581.ba"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041175"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.8.1057"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01458.x"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134791.68010.FA"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(91)90011-W"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000256651"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-51"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.4.846"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05059-5"},{"key":"e_1_3_3_20_2","volume-title":"European Stroke Conference","author":"Siebler M","year":"2006","unstructured":"Siebler M. Safety of tirofiban in acute ischemic stroke [Abstract]. European Stroke Conference, Brussels, Belgium, May 16\u201319, 2006."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.106.476648"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000275503"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3280116c36"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000109395.74740.1F"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.108.517656"},{"key":"e_1_3_3_26_2","unstructured":"University of Cincinnati. Study of the combination therapy of rt-PA and eptifibatide to treat acute ischemic stroke (CLEAR-ER). www.ClinicalTrials.gov. Bethesda MD: National Library of Medicine;2000 [cited February 22 2011]. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00894803. NLM Identifier: NCT00894803."},{"key":"e_1_3_3_27_2","volume-title":"International Stroke Conference\u2014late breaking abstracts","author":"Warach S","year":"2006","unstructured":"Warach S. Reopro retavase reperfusion of stroke safety study\u2014imaging evaluation. International Stroke Conference\u2014late breaking abstracts, Kissimmee, Florida, February 15\u201318, 2006."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000170707.86793.1a"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000199064.94588.39"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21723"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.563304"},{"key":"e_1_3_3_32_2","volume-title":"Combined lysis of thrombus in brain ischemia with transcranial ultrasound and systemic tPA\u2014hands-free. A Phase I\/II pilot safety trial. www.ClinicalTrials.gov","author":"The University of Texas Health Science Center, Houston","year":"2000","unstructured":"The University of Texas Health Science Center, Houston. Combined lysis of thrombus in brain ischemia with transcranial ultrasound and systemic tPA\u2014hands-free. A Phase I\/II pilot safety trial. www.ClinicalTrials.gov. Bethesda, MD: National Library of Medicine;2000 [cited February 22, 2011]. Available at: http:\/\/clinicaltrials.gov\/show\/NCT01240356. NLM Identifier: NCT01240356."},{"key":"e_1_3_3_33_2","volume-title":"www.ClinicalTrials.gov","author":"Cerevast Therapeutics","year":"2000","unstructured":"Cerevast Therapeutics. A randomized, active controlled, double-blinded trial of the combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator (tPA) for emergent revascularization (CLOTBUSTER) in acute ischemic stroke. www.ClinicalTrials.gov. Bethesda, MD: National Library of Medicine;2000 [cited September 22, 2011]. Available at: http:\/\/clinicaltrials.gov\/show\/NCT01098981. NLM Identifier: NCT01098981."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.10.2072"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000154872.73240.e9"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.572040"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000149938.08731.2c"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000217403.66996.6d"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70267-9"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.110.595157"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.9.1755"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.18.2395"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.565119"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69776-6"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.0b013e318208eb99"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b9c847"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.561274"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2008.00357.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.577502"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.107.512418"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.107.500132"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.547950"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ffe4e4"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2010.00551.x"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.110.600221"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(99)00557-6"},{"key":"e_1_3_3_57_2","unstructured":"BrainsGate. Implant for augmentation of cerebral blood flow trial effectiveness and safety in a 24 hour window (impact-24). www.ClinicalTrials.gov. Bethesda MD: National Library of Medicine;2000 [cited September 22 2011]. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00826059. NLM Identifier: NCT00826059."}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.111.617902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:31:14Z","timestamp":1715596274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.111.617902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1161\/STROKEAHA.111.617902"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.111.617902","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"2011-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-10-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}